| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $0.97 (Beat by $0.037) |
| EPS GAAP Actual | $0.97 (Beat by $0.037) |
| Revenue Actual | $6.439B |
| Revenue Surprise | Beat by $6439M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.51739 |
| EPS GAAP Estimate | $0.51739 |
| Revenue Estimate | $4.02014671B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 7.24934 | 18.79 | 6.39417 | 8.1708 | 1 |
| Dec 2028 | 4.91564 | 27.71 | 4.6976 | 5.1258 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.98 | 0 | 6.439B | 32.94% | 2705.43M |
| FQ3 2025 (Sep 2025) | 1.02 | 0.106 | 6.1944B | 34.8% | 2651.02M |
| FQ2 2025 (Jun 2025) | 0.9 | 0.0025000000000001 | 5.6503B | 36.11% | 2162.4M |
| FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 4.811B | 32.32% | 4811M |
| FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 4.3179B | 22.94% | 4317.9M |
| FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 4.0389B | 20.79% | 4038.9M |
| FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 3.6097B | 15.4% | 3609.7M |
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 3.2563B | 8.67% | 3256.3M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.51739
Consensus Revenue Estimates
4.02014671B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.86737 | -- | 0.80513 | 0.92525 | 6 |
| FQ3 2027 (Sep 2027) | 0.7101 | -- | 0.68866 | 0.74112 | 2 |
| FQ2 2027 (Jun 2027) | 0.6693 | -- | 0.64909 | 0.69854 | 2 |
| FQ1 2027 (Mar 2027) | 0.63392 | -- | 0.60315 | 0.66835 | 2 |
| FQ4 2026 (Oct 2026) | 1.0831 | 9.52 | 1.05288 | 1.11124 | 3 |
| FQ3 2026 (Jul 2026) | 1.0031 | -1.68 | 0.97511 | 1.02916 | 3 |
| FQ2 2026 (Jun 2026) | 0.54491 | -65.16 | 0.52322 | 0.5608 | 4 |
| FQ1 2026 (Mar 2026) | 0.51739 | -17.9 | 0.4968 | 0.53247 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.18B | -- | 5.83B | 6.49B | 7 |
| FQ3 2027 (Sep 2027) | 5.2B | -- | 5.08B | 5.37B | 3 |
| FQ2 2027 (Jun 2027) | 4.94B | -- | 4.83B | 5.11B | 3 |
| FQ1 2027 (Mar 2027) | 4.79B | -- | 4.61B | 4.99B | 3 |
| FQ4 2026 (Oct 2026) | 4.02B | -60.22 | 3.93B | 4.1B | 4 |
| FQ3 2026 (Jul 2026) | 3.81B | -62.65 | 3.73B | 3.88B | 4 |
| FQ2 2026 (Jun 2026) | 4.21B | -34.06 | 4.09B | 4.31B | 3 |
| FQ1 2026 (Mar 2026) | 4.02B | -19.67 | 3.9B | 4.11B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.98 | 0.98 | 0 | 0% |
| FQ3 2025 (Sep 2025) | 0.914 | 1.02 | 0.106 | 10.39% |
| FQ2 2025 (Jun 2025) | 0.8975 | 0.9 | 0.0025000000000001 | 0.28% |
| FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 100% | |
| FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 100% | |
| FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 100% | |
| FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 100% | |
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $3.73B | $6.44B | $2705.43M | 42.02% |
| FQ3 2025 (Sep 2025) | $3.54B | $6.19B | $2651.02M | 42.8% |
| FQ2 2025 (Jun 2025) | $3.49B | $5.65B | $2162.4M | 38.27% |
| FQ1 2025 (Mar 2025) | $0B | $4.81B | $4811M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.32B | $4317.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.04B | $4038.9M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.61B | $3609.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.26B | $3256.3M | 100% |